Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study
Abstract
Data di Pubblicazione:
2018
Citazione:
Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study / Russo, A; Ricci, F; Magagnoli, M; Rodari, M; Morello, L; Mazza, R; Chiti, A; Castagna, L; Santoro, A; Carlo-Stella, C. - In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. - ISSN 2152-2650. - 18:(2018), pp. 234-234. [10.1016/j.clml.2018.07.116]
Tipologia CRIS:
4.2 Abstract in Atti di convegno
Elenco autori:
Russo, A; Ricci, F; Magagnoli, M; Rodari, M; Morello, L; Mazza, R; Chiti, A; Castagna, L; Santoro, A; Carlo-Stella, C
Link alla scheda completa:
Titolo del libro:
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Pubblicato in: